Sort
64,565 grants matching “drug discovery”
ETIOLOGY OF SUBSTANCE USE IN AUSTRALIA /USA
$815,170University Of Washington · R01 · FY2001 · DA
Antibiotic dereplication by transcriptome analysis
$815,045Karen E. Nelson · Northeastern University · P01 · FY2016 · AI
Cell-free assay technologies for the identification of active compounds
$814,972Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Pharmacogenomics of HIV Therapy
$814,885David W Haas · Vanderbilt University Medical Center · R01 · FY2024 · AI
Administrative Core
$814,865James F Amatruda · Ut Southwestern Medical Center · U54 · FY2019 · CA
Validation of Modulators of PGRN as Novel Therapeutics for Frontotemporal Dementi
$814,811Joachim J Herz · Ut Southwestern Medical Center · R01 · FY2018 · NS
Second Generation Small Molecule Inhibitors of Botulinum Neurotoxins
$814,793Sina Bavari · Geneva Foundation · U01 · FY2009 · AI
Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics
$814,748Stephanie K Florio · Anagin · U44 · FY2024 · NS
Integrated genomics research in parasitic tropical diseases
$814,735Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2017 · AI
Mid Southern Primary Care Networks Node
$814,688Li-Tzy T Wu · Duke University · UG1 · FY2016 · DA
BMC--BHASIN
$814,436Shalendar Bhasin · Boston Medical Center · P30 · FY2011 · AG
Design And Development Of Experimental Therapeutics
$814,403Nigel H. Greig · National Institute On Aging · ZIA · FY2009 · AG
Discovery of small molecules inhibiting Toll-like receptor-mediated inflammation
$814,380Hans Haecker · University Of Utah · R01 · FY2019 · AI
Imaging epigenetic dysregulation in the Lewy body dementias with [11C]Martinostat
$814,349Stephen N. Gomperts · Massachusetts General Hospital · R01 · FY2025 · AG
Pharmacogenomics of HIV Therapy
$814,283David W Haas · Vanderbilt University Medical Center · R01 · FY2022 · AI
Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Trained Human Sensory Panels
$814,149Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2025 · AI
Discovery of Addiction-Related Genes with Advanced Mouse Resources
$814,071Elissa J Chesler · Jackson Laboratory · R01 · FY2023 · DA
High throughput tau oligomer drug screening assay for Alzheimer's disease
$814,009James G. Moe · Oligomerix, Inc · R44 · FY2014 · AG
DCTD Synthetic Chemistry
$813,796David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$813,788Alan David Levine · Case Western Reserve University · R01 · FY2016 · DA
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$813,788Alan David Levine · Case Western Reserve University · R01 · FY2017 · DA
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$813,788Alan David Levine · Case Western Reserve University · R01 · FY2020 · DA
Exploration, conservation, and development of marine bi*
$813,774Mark E Hay · Georgia Institute Of Technology · U01 · FY2006 · TW
TRANS STUDIES OF COGNITIVE,AFFECTIVE/NEUROCHEMICAL PROCESSES UNDERLYING INSISTENC
$813,744John A Sweeney · University Of Illinois At Chicago · P50 · FY2007 · HD
Tuned stem cell extracellular vesicles are a novel chronic wound therapeutic
$813,686Yolanda Renee Lea-Currie · Zen-Bio, Inc. · R44 · FY2019 · AG